1 Case Suspected of Miller Fisher Syndrome, Vaccine Causality Unclear

"Among 746 Vaccination Adverse Reaction Claims, 368 Cases Compensated for Medical and Caregiving Expenses" (Update) View original image

[Asia Economy Reporter Seo So-jeong] The Compensation Committee for Vaccine Injury (Chairman Kim Jung-gon) announced on the 12th that it held the 7th COVID-19 Vaccination Injury Compensation Committee meeting on the 10th and reviewed a total of 746 cases of compensation claims filed due to adverse reactions after vaccination, deciding to compensate medical and nursing care expenses for 368 of these cases.


The 368 cases approved for compensation involved adverse reactions such as fever, headache, muscle pain, dizziness, and allergic reactions after vaccination, accounting for nearly half (49.3%) of the total claims submitted.


The expert committee consists of 15 members, including clinical doctors, forensic scientists, experts in infectious diseases, immunology, microbiology, lawyers, and specialists recommended by civic groups.


At this meeting, one case suspected to be 'Miller Fisher Syndrome' was evaluated as having unclear causality with the vaccination. Miller Fisher Syndrome is a peripheral neuropathy characterized mainly by ophthalmoplegia, loss of motor function, and absence of deep tendon reflexes. To date, a total of 17 individuals have been confirmed eligible for medical expense support, and among them, medical expense support has been completed for 4 applicants.


Out of a total of 28,568,312 vaccinations, 133,037 cases were reported as suspected adverse reactions as of midnight on the 11th. Among these, 2,300 cases (1.7%) involved adverse reactions severe enough to visit medical institutions and filed compensation claims, which were reviewed up to the 7th committee meeting. Of these, 1,351 cases (58.7%) were approved for compensation.


The task force has also established a medical expense support program for severe patients excluded from compensation due to insufficient evidence of causality after COVID-19 vaccination, providing up to 10 million KRW per person for medical expenses.



The task force stated, "We plan to promptly provide support as other eligible individuals apply through their local city, county, or district health centers."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing